10-K Filing

KYNTRA BIO, INC. CIK: 921299 FY 2016

Filing Information

Form Type	10-K
Accession Number	`0001564590-17-003095`
Period End Date	20161231
Filing Date	20170301
Fiscal Year	2016
Fiscal Period	FY
XBRL Instance	fgen-20161231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 86 Income Statement 51 Cash Flow Statement 117 Stockholders Equity 32 Comprehensive Income 21

Balance Sheet 86 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable from related party	`AccountsReceivableRelatedPartiesCurrent`	$4.46M	USD	Point-in-time
Accounts receivable from related party	`AccountsReceivableRelatedPartiesCurrent`	$4.10M	USD	Point-in-time
Accrued liabilities to related parties	`DueToRelatedPartiesCurrent`	$1.61M	USD	Point-in-time
Accrued liabilities to related parties	`DueToRelatedPartiesCurrent`	$2.04M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$76.33M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$173.78M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$153.32M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$165.46M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Short-term investments	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$79.40M	USD	Point-in-time
Short-term investments	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$27.85M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	125.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	125.00M	shares	Point-in-time
Accounts receivable ($4,102 and $4,455 from a related party)	`AccountsReceivableNetCurrent`	$10.45M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable ($4,102 and $4,455 from a related party)	`AccountsReceivableNetCurrent`	$15.40M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.89M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.99M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total current assets	`AssetsCurrent`	$266.52M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$200.56M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	225.00M	shares	Point-in-time
Restricted time deposits	`RestrictedTimeDepositsNoncurrent`	$6.22M	USD	Point-in-time
Restricted time deposits	`RestrictedTimeDepositsNoncurrent`	$7.25M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	225.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	61.98M	shares	Point-in-time
Long-term investments	`AvailableForSaleSecuritiesNoncurrent`	$131.72M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	63.66M	shares	Point-in-time
Long-term investments	`AvailableForSaleSecuritiesNoncurrent`	$71.01M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	63.66M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	61.98M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$129.02M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$123.66M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$2.15M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$2.02M	USD	Point-in-time
Total assets	`Assets`	$470.57M	USD	Point-in-time
Total assets	`Assets`	$469.55M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.52M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.22M	USD	Point-in-time
Accrued liabilities ($1,615 and $2,045 to related parties)	`AccruedLiabilitiesCurrent`	$47.93M	USD	Point-in-time
Accrued liabilities ($1,615 and $2,045 to related parties)	`AccruedLiabilitiesCurrent`	$50.91M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$12.73M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$7.99M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$65.12M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$67.18M	USD	Point-in-time
Long-term portion of lease financing obligations	`LeaseFinancingObligationNoncurrent`	$97.35M	USD	Point-in-time
Long-term portion of lease financing obligations	`LeaseFinancingObligationNoncurrent`	$97.04M	USD	Point-in-time
Product development obligations	`AccruedProductDevelopmentCosts`	$14.85M	USD	Point-in-time
Product development obligations	`AccruedProductDevelopmentCosts`	$15.09M	USD	Point-in-time
Deferred rent	`DeferredRentCreditNoncurrent`	$4.70M	USD	Point-in-time
Deferred rent	`DeferredRentCreditNoncurrent`	$4.21M	USD	Point-in-time
Deferred revenue, net of current	`DeferredRevenueNoncurrent`	$85.13M	USD	Point-in-time
Deferred revenue, net of current	`DeferredRevenueNoncurrent`	$106.71M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$6.19M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$4.61M	USD	Point-in-time
Total liabilities	`Liabilities`	$294.44M	USD	Point-in-time
Total liabilities	`Liabilities`	$273.75M	USD	Point-in-time
Commitments and Contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.01 par value; 125,000 shares authorized at December 31, 2016 and December 31, 2015; no shares issued and outstanding at December 31, 2016 and December 31, 2015	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.01 par value; 125,000 shares authorized at December 31, 2016 and December 31, 2015; no shares issued and outstanding at December 31, 2016 and December 31, 2015	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value; 225,000 shares authorized at December 31, 2016 and December 31, 2015; 63,665 and 61,985 shares issued and outstanding at December 31, 2016 and December 31, 2015	`CommonStockValue`	$620.00K	USD	Point-in-time
Common stock, $0.01 par value; 225,000 shares authorized at December 31, 2016 and December 31, 2015; 63,665 and 61,985 shares issued and outstanding at December 31, 2016 and December 31, 2015	`CommonStockValue`	$637.00K	USD	Point-in-time
Stockholders' notes receivable	`StockholdersEquityNoteSubscriptionsReceivable`	-	USD	Point-in-time
Stockholders' notes receivable	`StockholdersEquityNoteSubscriptionsReceivable`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$586.65M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$625.90M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-960.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.65M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-408.06M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-469.74M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$155.84M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$177.55M	USD	Point-in-time
Non-controlling interests	`MinorityInterest`	$19.27M	USD	Point-in-time
Non-controlling interests	`MinorityInterest`	$19.27M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$175.11M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$240.68M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-60.83M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$196.82M	USD	Point-in-time
Total liabilities, stockholders equity and non-controlling interests	`LiabilitiesAndStockholdersEquity`	$469.55M	USD	Point-in-time
Total liabilities, stockholders equity and non-controlling interests	`LiabilitiesAndStockholdersEquity`	$470.57M	USD	Point-in-time

Income Statement 51 line items

Line Item	Tag	Value	Unit	Period
License and milestone revenue (includes $24,421, $18,701 and $14,453 from a related party)	`LicenseFeesAndMilestonesRevenue`	$137.35M	USD	Annual
License and milestone revenue (includes $24,421, $18,701 and $14,453 from a related party)	`LicenseFeesAndMilestonesRevenue`	$117.19M	USD	Annual
License and milestone revenue (includes $24,421, $18,701 and $14,453 from a related party)	`LicenseFeesAndMilestonesRevenue`	$148.09M	USD	Annual
Collaboration services and other revenue (includes $1,357, $2,895 and $3,535 from a related party)	`CollaborationServicesAndOtherRevenue`	$20.41M	USD	Annual
Collaboration services and other revenue (includes $1,357, $2,895 and $3,535 from a related party)	`CollaborationServicesAndOtherRevenue`	$42.23M	USD	Annual
Collaboration services and other revenue (includes $1,357, $2,895 and $3,535 from a related party)	`CollaborationServicesAndOtherRevenue`	$32.73M	USD	Annual
Total revenue	`Revenues`	$137.60M	USD	Annual
Total revenue	`Revenues`	$179.58M	USD	Annual
Total revenue	`Revenues`	$180.83M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$150.79M	USD	Annual
License and milestone revenue from a related party	`LicenseFeesAndMilestonesRevenue`	$137.35M	USD	Annual
License and milestone revenue from a related party	`LicenseFeesAndMilestonesRevenue`	$117.19M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$214.09M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$187.21M	USD	Annual
License and milestone revenue from a related party	`LicenseFeesAndMilestonesRevenue`	$148.09M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$46.02M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$36.91M	USD	Annual
Collaboration services and other revenue from a related party	`CollaborationServicesAndOtherRevenue`	$20.41M	USD	Annual
Collaboration services and other revenue from a related party	`CollaborationServicesAndOtherRevenue`	$42.23M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$44.36M	USD	Annual
Collaboration services and other revenue from a related party	`CollaborationServicesAndOtherRevenue`	$32.73M	USD	Annual
Total operating expenses	`OperatingExpenses`	$233.23M	USD	Annual
Total operating expenses	`OperatingExpenses`	$187.70M	USD	Annual
Total operating expenses	`OperatingExpenses`	$258.45M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-53.65M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-77.62M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-50.10M	USD	Annual
Interest expense	`InterestExpense`	$11.03M	USD	Annual
Interest expense	`InterestExpense`	$10.72M	USD	Annual
Interest expense	`InterestExpense`	$11.11M	USD	Annual
Interest income and other, net	`InterestAndOtherIncome`	$3.12M	USD	Annual
Interest income and other, net	`InterestAndOtherIncome`	$2.63M	USD	Annual
Interest income and other, net	`InterestAndOtherIncome`	$1.71M	USD	Annual
Total interest and other, net	`InterestIncomeExpenseNonoperatingNet`	$-8.10M	USD	Annual
Total interest and other, net	`InterestIncomeExpenseNonoperatingNet`	$-9.40M	USD	Annual
Total interest and other, net	`InterestIncomeExpenseNonoperatingNet`	$-7.91M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-61.75M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-85.54M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-59.50M	USD	Annual
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$242.00K	USD	Annual
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-71.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-85.78M	USD	Annual
Net loss	`NetIncomeLoss`	$-61.68M	USD	Annual
Net loss	`NetIncomeLoss`	$-59.50M	USD	Annual
Net loss per share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.98	USD	Annual
Net loss per share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-3.17	USD	Annual
Net loss per share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.42	USD	Annual
Weighted average number of common shares used to calculate net loss per share - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	60.34M	shares	Annual
Weighted average number of common shares used to calculate net loss per share - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	18.77M	shares	Annual
Weighted average number of common shares used to calculate net loss per share - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	62.74M	shares	Annual

Cash Flow Statement 117 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable from related party	`IncreaseDecreaseInAccountsReceivableRelatedParties`	$353.00K	USD	Annual
Accounts receivable from related party	`IncreaseDecreaseInAccountsReceivableRelatedParties`	$578.00K	USD	Annual
Accounts receivable from related party	`IncreaseDecreaseInAccountsReceivableRelatedParties`	$979.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-85.78M	USD	Annual
Accrued liabilities from related party	`IncreaseDecreaseInAccountsPayableRelatedParties`	$1.83M	USD	Annual
Net loss	`NetIncomeLoss`	$-61.68M	USD	Annual
Net loss	`NetIncomeLoss`	$-59.50M	USD	Annual
Accrued liabilities from related party	`IncreaseDecreaseInAccountsPayableRelatedParties`	$-2.55M	USD	Annual
Accrued liabilities from related party	`IncreaseDecreaseInAccountsPayableRelatedParties`	$-430.00K	USD	Annual
Depreciation	`Depreciation`	$4.47M	USD	Annual
Depreciation	`Depreciation`	$5.68M	USD	Annual
Depreciation	`Depreciation`	$6.04M	USD	Annual
Amortization of premium on investments	`InvestmentIncomeAmortizationOfPremium`	$2.73M	USD	Annual
Amortization of premium on investments	`InvestmentIncomeAmortizationOfPremium`	$658.00K	USD	Annual
Amortization of premium on investments	`InvestmentIncomeAmortizationOfPremium`	$3.00M	USD	Annual
Loss on disposal of property and equipment	`GainLossOnDispositionOfAssets`	-	USD	Annual
Loss on disposal of property and equipment	`GainLossOnDispositionOfAssets`	$10.00K	USD	Annual
Loss on disposal of property and equipment	`GainLossOnDispositionOfAssets`	$-98.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$27.68M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$32.13M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$18.70M	USD	Annual
Tax benefit on unrealized gain on available-for-sale securities	`AvailableForSaleSecuritiesIncomeTaxExpenseOnChangeInUnrealizedHoldingGainOrLoss`	$-211.00K	USD	Annual
Tax benefit on unrealized gain on available-for-sale securities	`AvailableForSaleSecuritiesIncomeTaxExpenseOnChangeInUnrealizedHoldingGainOrLoss`	-	USD	Annual
Tax benefit on unrealized gain on available-for-sale securities	`AvailableForSaleSecuritiesIncomeTaxExpenseOnChangeInUnrealizedHoldingGainOrLoss`	-	USD	Annual
Realized gain on sales of available-for-sale securities	`AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments`	$203.00K	USD	Annual
Realized gain on sales of available-for-sale securities	`AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments`	-	USD	Annual
Realized gain on sales of available-for-sale securities	`AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments`	$37.00K	USD	Annual
Accounts receivable ($353, $578 and $979 from related party)	`IncreaseDecreaseInAccountsReceivable`	$-4.04M	USD	Annual
Accounts receivable ($353, $578 and $979 from related party)	`IncreaseDecreaseInAccountsReceivable`	$1.95M	USD	Annual
Accounts receivable ($353, $578 and $979 from related party)	`IncreaseDecreaseInAccountsReceivable`	$-4.96M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.10M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-978.00K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.63M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$420.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$136.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$795.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.97M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.48M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-298.00K	USD	Annual
Accrued liabilities ($(430), $(2,549) and $1,828 from related party)	`IncreaseDecreaseInAccruedLiabilities`	$-2.13M	USD	Annual
Accrued liabilities ($(430), $(2,549) and $1,828 from related party)	`IncreaseDecreaseInAccruedLiabilities`	$2.96M	USD	Annual
Accrued liabilities ($(430), $(2,549) and $1,828 from related party)	`IncreaseDecreaseInAccruedLiabilities`	$18.88M	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$16.84M	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$27.65M	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$33.56M	USD	Annual
Lease financing liability	`IncreaseDecreaseInLeaseFinancingLiability`	$627.00K	USD	Annual
Lease financing liability	`IncreaseDecreaseInLeaseFinancingLiability`	$814.00K	USD	Annual
Lease financing liability	`IncreaseDecreaseInLeaseFinancingLiability`	$814.00K	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$4.22M	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-250.00K	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$1.90M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$7.11M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-18.57M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$22.41M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.98M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.25M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.12M	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$10.00K	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$2.00K	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	Annual
Purchases of available-for-sale securities	`PaymentsToAcquireAvailableForSaleSecurities`	$41.74M	USD	Annual
Purchases of available-for-sale securities	`PaymentsToAcquireAvailableForSaleSecurities`	$144.73M	USD	Annual
Purchases of available-for-sale securities	`PaymentsToAcquireAvailableForSaleSecurities`	$9.04M	USD	Annual
Proceeds from sales of available-for-sale securities	`ProceedsFromSaleOfAvailableForSaleSecurities`	-	USD	Annual
Proceeds from sales of available-for-sale securities	`ProceedsFromSaleOfAvailableForSaleSecurities`	$4.30M	USD	Annual
Proceeds from sales of available-for-sale securities	`ProceedsFromSaleOfAvailableForSaleSecurities`	$15.34M	USD	Annual
Proceeds from maturities of available-for-sale securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$45.55M	USD	Annual
Proceeds from maturities of available-for-sale securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$12.62M	USD	Annual
Proceeds from maturities of available-for-sale securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$22.50M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-5.87M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$6.62M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-107.29M	USD	Annual
Repayments of lease liability	`RepaymentsOfLongTermCapitalLeaseObligations`	$403.00K	USD	Annual
Repayments of lease liability	`RepaymentsOfLongTermCapitalLeaseObligations`	$403.00K	USD	Annual
Repayments of lease liability	`RepaymentsOfLongTermCapitalLeaseObligations`	$403.00K	USD	Annual
Proceeds from initial public offering, net of underwriting discounts and commission costs	`ProceedsFromInitialPublicOfferingNetOfUnderwritingDiscountsAndCommissionCosts`	$155.93M	USD	Annual
Proceeds from initial public offering, net of underwriting discounts and commission costs	`ProceedsFromInitialPublicOfferingNetOfUnderwritingDiscountsAndCommissionCosts`	-	USD	Annual
Proceeds from initial public offering, net of underwriting discounts and commission costs	`ProceedsFromInitialPublicOfferingNetOfUnderwritingDiscountsAndCommissionCosts`	-	USD	Annual
Proceeds from AstraZeneca private placement	`ProceedsFromIssuanceOfPrivatePlacement`	$20.00M	USD	Point-in-time
Proceeds from AstraZeneca private placement	`ProceedsFromIssuanceOfPrivatePlacement`	$20.00M	USD	Annual
Proceeds from AstraZeneca private placement	`ProceedsFromIssuanceOfPrivatePlacement`	-	USD	Annual
Proceeds from AstraZeneca private placement	`ProceedsFromIssuanceOfPrivatePlacement`	-	USD	Annual
Cash paid for payroll taxes on restricted stock unit releases	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$2.24M	USD	Annual
Cash paid for payroll taxes on restricted stock unit releases	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	Annual
Cash paid for payroll taxes on restricted stock unit releases	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$2.74M	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$14.99M	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$9.88M	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.70M	USD	Annual
Payments of deferred offering costs	`PaymentsOfStockIssuanceCosts`	-	USD	Annual
Payments of deferred offering costs	`PaymentsOfStockIssuanceCosts`	$3.13M	USD	Annual
Payments of deferred offering costs	`PaymentsOfStockIssuanceCosts`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$174.09M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$6.74M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$12.35M	USD	Annual
Effect of exchange rate change on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$-38.00K	USD	Annual
Effect of exchange rate change on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$-94.00K	USD	Annual
Effect of exchange rate change on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$-10.00K	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$89.12M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-12.13M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$20.46M	USD	Annual
Total cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$76.33M	USD	Point-in-time
Total cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$173.78M	USD	Point-in-time
Total cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$153.32M	USD	Point-in-time
Total cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$165.46M	USD	Point-in-time
Total cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$76.33M	USD	Point-in-time
Total cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$173.78M	USD	Point-in-time
Total cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$153.32M	USD	Point-in-time
Total cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$165.46M	USD	Point-in-time
Interest payments	`InterestPaidNet`	$295.00K	USD	Annual
Interest payments	`InterestPaidNet`	$335.00K	USD	Annual
Interest payments	`InterestPaidNet`	$377.00K	USD	Annual
Balance in accounts payable and accrued liabilities related to purchases of property and equipment	`CapitalExpendituresIncurredButNotYetPaid`	$356.00K	USD	Annual
Balance in accounts payable and accrued liabilities related to purchases of property and equipment	`CapitalExpendituresIncurredButNotYetPaid`	$280.00K	USD	Annual
Balance in accounts payable and accrued liabilities related to purchases of property and equipment	`CapitalExpendituresIncurredButNotYetPaid`	$931.00K	USD	Annual
Deferred offering costs recorded in accounts payable and accrued liabilities	`LiabilitiesAssumed1`	$974.00K	USD	Annual
Deferred offering costs recorded in accounts payable and accrued liabilities	`LiabilitiesAssumed1`	-	USD	Annual
Deferred offering costs recorded in accounts payable and accrued liabilities	`LiabilitiesAssumed1`	-	USD	Annual

Stockholders Equity 32 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$175.11M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$240.68M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-60.83M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$196.82M	USD	Point-in-time
Net loss	`NetIncomeLoss`	$-85.78M	USD	Annual
Net loss	`NetIncomeLoss`	$-61.68M	USD	Annual
Net loss	`NetIncomeLoss`	$-59.50M	USD	Annual
Change in unrealized loss on investments	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-164.00K	USD	Annual
Change in unrealized loss on investments	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$159.00K	USD	Annual
Change in unrealized loss on investments	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-1.72M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$1.66M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$532.00K	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$2.08M	USD	Annual
Stock options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$10.11M	USD	Annual
Stock options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$5.91M	USD	Annual
Stock options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.69M	USD	Annual
Shares issued upon vesting of restricted stock units, net of payroll taxes paid, and purchases made under the employee stock purchase plan	`SharesIssuedUponVestingOfRestrictedStockUnitsNetOfPayrollTaxesPaidAndPurchasesMadeUnderTheEmployeeStockPurchasePlan`	$1.23M	USD	Annual
Shares issued upon vesting of restricted stock units, net of payroll taxes paid, and purchases made under the employee stock purchase plan	`SharesIssuedUponVestingOfRestrictedStockUnitsNetOfPayrollTaxesPaidAndPurchasesMadeUnderTheEmployeeStockPurchasePlan`	$2.60M	USD	Annual
True up of issuance costs related to initial public offering and common stock sold by FibroGen Europe	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsAndSaleOfCommonStock`	$42.00K	USD	Annual
Stock appreciation rights settled	`StockIssuedDuringPeriodValueShareBasedCompensation`	-	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$27.68M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$18.70M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$32.13M	USD	Annual
Conversion of preferred stock to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$168.44M	USD	Annual
Initial Public Offering, net of underwriting discounts, commission and issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$151.83M	USD	Annual
Initial Public Offering, net of underwriting discounts, commission and issuance costs, shares	`StockIssuedDuringPeriodSharesNewIssues`	9.31M	shares	Point-in-time
Warrants exercised	`WarrantsExercisedDuringPeriodValue`	-	USD	Annual
Warrants exercised	`WarrantsExercisedDuringPeriodValue`	-	USD	Annual
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$175.11M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$240.68M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-60.83M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$196.82M	USD	Point-in-time

Comprehensive Income 21 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-85.78M	USD	Annual
Net loss	`NetIncomeLoss`	$-61.68M	USD	Annual
Net loss	`NetIncomeLoss`	$-59.50M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$1.66M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$532.00K	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$2.08M	USD	Annual
Unrealized gain (loss) on investments, net of tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$30.00K	USD	Annual
Unrealized gain (loss) on investments, net of tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$140.00K	USD	Annual
Unrealized gain (loss) on investments, net of tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-965.00K	USD	Annual
Reclassification from accumulated other comprehensive gain (loss)	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$-19.00K	USD	Annual
Reclassification from accumulated other comprehensive gain (loss)	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$194.00K	USD	Annual
Reclassification from accumulated other comprehensive gain (loss)	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$758.00K	USD	Annual
Net change in unrealized gain (loss) on available-for-sale investments	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-164.00K	USD	Annual
Net change in unrealized gain (loss) on available-for-sale investments	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$159.00K	USD	Annual
Net change in unrealized gain (loss) on available-for-sale investments	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-1.72M	USD	Annual
Other comprehensive income, net of taxes	`OtherComprehensiveIncomeLossNetOfTax`	$359.00K	USD	Annual
Other comprehensive income, net of taxes	`OtherComprehensiveIncomeLossNetOfTax`	$691.00K	USD	Annual
Other comprehensive income, net of taxes	`OtherComprehensiveIncomeLossNetOfTax`	$1.50M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-84.28M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-59.15M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-60.99M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.